Prestige Consumer Healthcare Inc. (PBH)

NYSE: PBH · Real-Time Price · USD

49.06

+0.31 (0.64%)

At close: Oct 30, 2026, 4:00 PM EDT

49.06

0.00 (0.00%)

After-hours: Oct 30, 2026, 7:00 PM EDT

Revenue Breakdown

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016	Mar '15 Mar 31, 2015	Mar '14 Mar 31, 2014	Mar '13 Mar 31, 2013
North American OTC Healthcare Revenue	927.20M	913.58M	960.01M
International OTC Healthcare Revenue	177.68M	175.13M	177.75M
Revenue (Total)	1.10B	1.09B	1.14B

Revenue Breakdown 2

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016	Mar '15 Mar 31, 2015	Mar '14 Mar 31, 2014	Mar '13 Mar 31, 2013
Cough, Cold & Allergy Revenue	104.21M	101.91M	106.21M
Dermatologicals Revenue	129.02M	125.93M	128.95M
Eye & Ear Care Revenue	143.61M	142.94M	183.32M
Gastrointestinal Revenue	264.21M	259.79M	255.94M
Oral Care Revenue	101.71M	101.05M	95.03M
Pain Relief Revenue	111.81M	113.94M	117.70M
Wellness, Sleep & Other OTC Revenue	26.78M	15.39M	13.78M
Women's Health Revenue	223.55M	227.77M	236.83M
Revenue (Total)	1.10B	1.09B	1.14B

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016	Mar '15 Mar 31, 2015	Mar '14 Mar 31, 2014	Mar '13 Mar 31, 2013
North American OTC Healthcare Gross Margin	496.42M	500.88M	531.14M
International OTC Healthcare Gross Margin	95.02M	94.70M	103.32M
Gross Profit (Total)	591.44M	595.58M	634.46M

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016	Mar '15 Mar 31, 2015	Mar '14 Mar 31, 2014	Mar '13 Mar 31, 2013
North American OTC Healthcare Contribution Margin	375.60M	380.03M	401.71M
International OTC Healthcare Contribution Margin	67.33M	66.77M	77.03M
Gross Profit (Other)	148.51M	148.78M	155.72M
Gross Profit (Total)	591.44M	595.58M	634.46M